Clinical utility of left ventricular strain, wall stress and serum brain natriuretic peptide levels in chronic hemodialysis patients

被引:4
作者
Shawky, Abeer M. [1 ]
Hamdy, Rehab M. [1 ]
Elmadbouly, Asmaa A. [2 ]
机构
[1] Al Azhar Univ, Fac Med Girls, Dept Cardiol, Cairo, Egypt
[2] Al Azhar Univ, Fac Med Girls, Dept Clin Pathol, Cairo, Egypt
关键词
ESRD; Hemodialysis; Brain natriuretic peptide;
D O I
10.1016/j.ehj.2018.05.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left ventricular (LV) global longitudinal strain (GLS) reliably assesses LV systolic function. The precise relation between LV wall stress and serum Brain natriuretic peptide (BNP) concentrations in hemodialysis (HD) patients needs to be clarified. BNP levels are raised in patients with end-stage renal disease (ESRD) and could reflect LV impairment among HD patients. Aim of this work: This study sought to evaluate the clinical utility of LV-GLS, wall stress and serum BNP levels in chronic HD patients. The correlations between BNP levels with both LV wall stress and LV-GLS were assessed. Patients and methods: 30 ESRD patients on regular HD {categorized into 15 patients with LV ejection fraction (EF) <= 50% and 15 patients with LV EF > 50%} and 15-age matched healthy subjects were included. LV function and structure were assessed by conventional echocardiography including LV meridional wall stress (LVMWS), LV mass index (LVMI) and 2-dimensional speckle tracking echocardiography for determination of LV-GLS. Serum BNP levels were evaluated after HD session. Results: There were significant increase of LVMSW (189.2 +/- 81 vs. 72.2 +/- 20.6 dynes/cm(2) x 1000, P < 0.0001), higher levels of BNP (1238 +/- 1085.5 vs. 71 +/- 23.4 pg/ml, P < 0.0001) while LV-GLS was significantly reduced (15.1 +/- 3.1 vs. 20.8 +/- 1.7%, P < 0.0001) in HD patients compared to controls. Higher values of LVMWS (246.9 +/- 67.5 vs. 131.5 +/- 43.6 dynes/cm(2) x 1000, P < 0.0001) and BNP (1925.4 +/- 1087 vs. 550.5 +/- 496.5 pg/ml, P < 0.0005) with further impairment of LV-GLS (13.8 +/- 2.5 vs. 16.4 +/- 5.4%, P < 0.05) were found in patients with LV EF <= 50% than those with LV EF > 50%. Serum levels of BNP were positively correlated with LVMI (r = 0.896, P < 0.0001) and LVMWS (r = 0.697, P < 0.0001) but negatively correlated with LV-GLS (r = -0.587, P < 0.0001). Conclusion: LV-GLS and LVMWS are useful imaging markers for detection of LV dysfunction in HD patients. Serum BNP level is influenced by LV structural abnormalities and suggested to be a crucial hemodynamic biomarker in those patients. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:329 / 335
页数:7
相关论文
共 35 条
  • [1] AKIBA T, 1995, CLIN NEPHROL, V44, pS61
  • [2] Alhaj Eyad, 2013, Congest Heart Fail, V19, pE40, DOI 10.1111/chf.12030
  • [3] Noninvasive myocardial strain measurement by speckle tracking echocardiography - Validation against sonomicrometry and tagged magnetic resonance imaging
    Amundsen, BH
    Helle-Valle, T
    Edvardsen, T
    Torp, H
    Crosby, J
    Lyseggen, E
    Stoylen, A
    Ihlen, H
    Lima, JAC
    Smiseth, OA
    Slordahl, SA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 789 - 793
  • [4] Bavbek N, 2007, PERITON DIALYSIS INT, V27, P663
  • [5] Global Longitudinal Strain Predicts Long-Term Survival in Patients With Chronic Ischemic Cardiomyopathy
    Bertini, Matteo
    Ng, Arnold C. T.
    Antoni, M. Louisa
    Nucifora, Gaetano
    Ewe, See H.
    Auger, Dominique
    Marsan, Nina Ajmone
    Schalij, Martin J.
    Bax, Jeroen J.
    Delgado, Victoria
    [J]. CIRCULATION-CARDIOVASCULAR IMAGING, 2012, 5 (03) : 383 - 391
  • [6] Bjellerup P, 2006, DAILY DIALYSES DECRE, V394, P394
  • [7] Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling
    Cataliotti, A
    Malatino, LS
    Jougasaki, M
    Zoccali, C
    Castellino, P
    Giacone, G
    Bellanuova, I
    Tripepi, R
    Seminara, G
    Parlongo, S
    Stancanelli, B
    Bonanno, G
    Fatuzzo, P
    Rapisarda, F
    Belluardo, P
    Signorelli, SS
    Heublein, DM
    Lainchbury, JG
    Leskinen, HK
    Bailey, KR
    Redfield, MM
    Burnett, JC
    [J]. MAYO CLINIC PROCEEDINGS, 2001, 76 (11) : 1111 - 1119
  • [8] Charfeddine S, 2016, ARCH CARDIOVASC DI S, V8, p[0522, 50]
  • [9] ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article
    Cheitlin, MD
    Armstrong, WF
    Aurigemma, GP
    Beller, GA
    Bierman, FZ
    Davis, JL
    Douglas, PS
    Faxon, DP
    Gillam, LD
    Kimball, TR
    Kussmaul, WG
    Pearlman, AS
    Philbrick, JT
    Rakowski, H
    Thys, DM
    Antman, EM
    Smith, SC
    Alpert, JS
    Gregoratos, G
    Anderson, JL
    Hiratzka, LF
    Faxon, DP
    Hunt, SA
    Fuster, V
    Jacobs, AK
    Gibbons, RJ
    Russell, RO
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) : 954 - 970
  • [10] United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease
    Collins, Allan J.
    Foley, Robert N.
    Gilbertson, David T.
    Chen, Shu-Cheng
    [J]. KIDNEY INTERNATIONAL SUPPLEMENTS, 2015, 5 (01) : 2 - 7